In this study, three out of four patients (ID–050, ID-2-13, ID–032) with pathogenic MSH6 mutations had cancer early in life (Table 1), and patient LS–050 had endometrial cancer as her first tumor at the age of 49, which is a hallmark of MSH6 mutation carriers [40]. Here, MSH6 is linked to cancer.